Altered pathways of urinary corticosteroid excretion in liver disease studied by a clinical laboratory method.
D015065:17-Hydroxycorticosteroids / Q000652:urine*; D015068:17-Ketosteroids / Q000652:urine*; D000305:Adrenal Cortex Hormones / Q000652:urine*; D000311:Adrenal Glands / Q000503:physiopathology; D000324:Adrenocorticotropic Hormone / Q000378:metabolism; D005234:Fatty Liver / Q000209:etiology / Q000652:urine*; D005260:Female; D005966:Glucuronidase; D006018:Glycols / Q000652:urine; D006801:Humans; D006854:Hydrocortisone / Q000378:metabolism*; D008103:Liver Cirrhosis / Q000652:urine*; D008297:Male; D008722:Methods; D008797:Metyrapone / Q000378:metabolism*; D006899:Mixed Function Oxygenases / Q000037:antagonists & inhibitors; D008954:Models, Biological; D013223:Statistics as Topic
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D000305:Adrenal Cortex Hormones; D006018:Glycols; D000324:Adrenocorticotropic Hormone; D006899:Mixed Function Oxygenases; D005966:Glucuronidase; D006854:Hydrocortisone; D008797:Metyrapone